Context: The in-house techniques or experimental methods are increasingly
recommended for their low-cost reagents for the determination of the Viral Load
(VL) in resource-limited settings. The objective of this study was to compare
the determination of VL from HIV-1 non-B samples by an in-house technique with
the COBAS AmpliPrep/TaqMan version 2.0. Method: In this cross-sectional
study, 39 plasma samples from patients infected with HIV type 1 non-B from N’Djamena
and Kinshasa were used to determine the VL using the two techniques. Results: The
mean values of VL are respectively 4.68 ±
1.26 and 4.58 ± 1.33 log10 RNA copies/ml for the COBAS AmpliPrep/TaqMan
assays and the in-house assays. A good correlation (Spearman Correlation) was
obtained, with a coefficient (R2) of 0.9452. Conclusion: This study
demonstrates that there is no significant difference between the results of VL
determined by the COBAS AmpliPrep/TaqMan assays and the in-house assays used.
Cite this paper
Kamangu, E. N. , Chatte, A. , Boreux, R. , Susin, F. , Kalala, R. L. , Mvumbi, G. L. , Mol, P. D. , Hayette, M. and Vaira, D. (2015). Comparison of an In-House Quantitative Real-Time PCR and COBAS AmpliPrep/TaqMan Roche for Determination of Viral Load for HIV Type 1 Non-B. Open Access Library Journal, 2, e1402. doi: http://dx.doi.org/10.4236/oalib.1101402.
Department of Health and Human Services (DHHS) (2011) Guidelines
for the Use of Antiretroviral Agents in HIV- Infected Adults and Adolescents. US Government Printing Office, Washington DC, 174.
World Health Organization (WHO) (2006) Towards Universal Access
by 2010. How WHO Is Working with Countries to Scale-Up HIV Prevention, Treatment,
Care and Support. World Health Organization, Geneva. www.who.int/hiv/universalaccess2010
World Health Organization
(WHO) (2010) Antiretroviral Therapy for HIV Infection in Adults and Adolescents:
Recommendations for a Public Health Approach (2010 Revision). World Health
Organization, Geneva. www.who.int/publications/2010/9789241599764_eng.pdf
Steegen, K., Luchters, S.S., De Cabooter, N., Reynaerts, J., Mandaliya, K., Plum, J., Jaoko, W., Verhofstede, C. and Temmerman, M. (2007) Evaluation of Two
Commercially Available Alternatives for HIV-1 Viral Load Testing in Resource-Limited
Setting. Journal of Virological Methods, 146, 178-187. http://dx.doi.org/10.1016/j.jviromet.2007.06.019
Rouet, F., Chaix, M.L., Nerrienet, E., Ngo-Giang-Huong, N., Plantier, J.C., Burgard, M., Peeters, M., Damond, F., Koumavi, E.D., Msellati, P., Ferradini, L., Rukobo, S., Maréchal, V., Schvachsa, N., Wakrim, L., Rafalimanana, C., Rakotoambibiba, B., Viard, J.P., Seigneurin, J.M., Rouzioux, C. and for the Agence Nationale de Recherchessur le
SIDA AC11/AC12 Working Groups (2007) Impact of HIV-1 Genetic Diversity on Plasma HIV-1 RNA
Quantification. Journal of Acquired
Immune Deficiency Syndromes, 45, 380-388. http://dx.doi.org/10.1097/QAI.0b013e3180640cf5
Rouet, F., Foulongne, V., Viljoen, J., Steegen, K., Becquart, P., Valéa, D., Danaviah, S., Segondy, M., Verhofstede, C., Van de Perre, P. and for the WHO/ANRS 1289 Kesho Bora Study Group (2010) Comparison of
the Generic HIV Viral LoadAssay with AmplicorTM HIV-1
Monitoring v1.5 and Nuclisens HIV-1 EasyQ v1.2 Techniques for Plasma
HIV-1 RNA Quantification of Non-B Subtypes: The Kesho Bora Preparatory Study. Journal of Virological Methods, 163, 253-257. http://dx.doi.org/10.1016/j.jviromet.2009.10.005
Drosten, C., Panning, M., Drexler, J.F., Hansel, F., Pedrosoc, C., Yeats, J., de Souza Luna, L.K., Samuel, M., Liedigk, B., Lippert, U., Stürmer, M., Doerr, H.W., Brites, C. and Preiser, W. (2006) Ultrasensitive Monitoring
of HIV-1 Viral Load by a Low-Cost Real-Time Reverse Transcription-PCR Assay with
Internal Control for 5’ Long Terminal Repeat Domain.Clinical Chemistry, 52, 1258-1266. http://dx.doi.org/10.1373/clinchem.2006.066498
Steegen, K., Demecheleer, E., De Cabooter, N., Nges, D., Temmerman, M., Ndumbe, P., Mandaliya, K., Plum, J. and Verhofstede, C. (2006) A Sensitive In-House RT-PCR Genotyping System for
Combined Detection of Plasma HIV-1 and Assessment of Drug Resistance. Journal of Virological Methods, 133, 137-145. http://dx.doi.org/10.1016/j.jviromet.2005.11.004
Adawaye, C., Kamangu, N.E., Moussa, A.M., Tchombou, H.Z.B., Vaira, D. and Moutshen, M. (2015) Prévalence de la résistance acquise et
diversité génétique des souches du VIH-1 circulant à Ndjamena au Tchad. In Press.
Kamangu, N.E., Adawaye, C., Susin, F., Boreux, R., Kalala, L.R., Mvumbi, L.G., De Mol, P., Vaira, D. and Hayette, M.P. (2015) Genetic
Diversity and Antiretroviral Drug Resistance among Drug-Naive HIV Type 1
Infected Patients Attending Clinics in Kinshasa, Democratic Republic of Congo.
In Press.
Kamangu, N.E., Kabututu, Z., Mvumbi, L.G., Kalala, L.R. and Mesia, K.G. (2013)
Genetic Diversity of Human Immunodeficiency Virus Type 1 in the Democratic
Republic of Congo. International Journal
of Collaborative Research on Internal Medicine & Public Health (IJCRIMPH), 5, 295-309.
Kamangu, N.E., Kalala, N.H. and Mesia, K.G. (2012) Profile of
Antiretroviral Treatment Centers in Kinshasa, Democratic Republic of Congo
[Poster 388]. Proceedings of the 1st International African Society of
Laboratory Medicine (ASLM) Conference, Cape Town, 1-7 December 2012, 377.
